CHOICE:Decision Factor of EGFR-TKI in Chinese IV NSCLC

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2026
This non-interventional, cross-sectional study aims to investigate treatment preferences from a sample of physicians and patients with experience of 1L EGFR-TKI for stage IV NSCLC by administering a survey, which primarily includes a DCE approach.
Epistemonikos ID: bba5c3bc8245a740fb4b9fd4d015c9c005ca6bb6
First added on: Feb 18, 2026